An elevated level of serum amyloid P component (SAP) in a sample of cerebrospinal fluid from a subject relative to the level of SAP found in samples of cerebrospinal fluid from healthy individuals and/or individuals with a neurological disease other than Alzheimer's disease is indicative of Alzheimer's disease. Measurement of levels of SAP in cerebrospinal fluid enables diagnosis of Alzheimer's disease and/or monitoring of the progress of the disease.
申请公布号
WO9514234(A1)
申请公布日期
1995.05.26
申请号
WO1994GB02559
申请日期
1994.11.21
申请人
ROYAL POSTGRADUATE MEDICAL SCHOOL;PEPYS, MARK, BRIAN;HAWKINS, PHILIP, NIGEL